Search results for " Preconditioning"

showing 10 items of 31 documents

Remote Ischemic Preconditioning Decreases Oxidative Lung Damage After Pulmonary Lobectomy

2017

BACKGROUND:During lobectomy in patients with lung cancer, the operated lung is often collapsed and hypoperfused. Ischemia/reperfusion injury may then occur when the lung is re-expanded. We hypothesized that remote ischemic preconditioning (RIPC) would decrease oxidative lung damage and improve gas e

Lungbusiness.industryIschemiaHemodynamicsrespiratory system030204 cardiovascular system & hematologyLung injurymedicine.diseasemedicine.disease_causerespiratory tract diseases03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicinemedicine.anatomical_structure030228 respiratory systemAnesthesiamedicineIschemic preconditioningbusinessLung cancerReperfusion injuryOxidative stressAnesthesia & Analgesia
researchProduct

Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices.

1999

Sublethal anoxia/ischemia protects against subsequent damaging insults in intact brain or hippocampal slices. To help further understand mechanisms underlying anoxic/ischemic preconditioning, we tested three hypotheses which were that: (a) anoxic preconditioning (APC) improves electrical recovery in rat hippocampal slices; (b) anoxic preconditioning requires nitric oxide (NO); and (c) anoxic preconditioning blocks mitochondrial dysfunction that occurs following re-oxygenation after anoxia. Control hippocampal slices underwent a single 'test' anoxic insult. Experimental slices were preconditioned by 3 short anoxic insults prior to the 'test' insult. Evoked potentials (EPs), and NADH redox st…

MaleCentral nervous systemIschemiaHippocampusPharmacologyMitochondrionHippocampal formationIn Vitro TechniquesNitric OxideNeuroprotectionHippocampusNitric oxidechemistry.chemical_compoundmedicineAnimalsRats WistarHypoxia BrainIschemic PreconditioningMolecular Biologybusiness.industryGeneral Neurosciencemedicine.diseaseNADRatsmedicine.anatomical_structureNeuroprotective AgentschemistrySynapsesIschemic preconditioningNeurology (clinical)businessNeuroscienceOxidation-ReductionDevelopmental BiologyBrain research
researchProduct

Induction of Cerebral Ischemic Tolerance by Erythromycin Preconditioning Reprograms the Transcriptional Response to Ischemia and Suppresses Inflammat…

2007

Background A single dose of the macrolide antibiotic erythromycin can induce tolerance against cerebral ischemia in vivo (pharmacologic preconditioning). This study identified potential mechanisms of tolerance induction by assessing effects of erythromycin preconditioning on the cerebral transcriptional response to transient global cerebral ischemia. Methods Preconditioned and nonpreconditioned rats were exposed to 15 min of global cerebral ischemia, and changes in cerebral gene expression were identified by complementary DNA expression array and quantified by real-time reverse-transcription polymerase chain reaction. Results Ischemia caused a widespread up-regulation of transcription in n…

MaleDNA ComplementaryTranscription GeneticIschemiaInflammationPharmacologyNeuroprotectionBrain IschemiaProinflammatory cytokineIn vivoGene expressionmedicineAnimalsRNA MessengerRats WistarIschemic PreconditioningAntibacterial agentInflammationReverse Transcriptase Polymerase Chain Reactionbusiness.industryBrainmedicine.diseaseAnti-Bacterial AgentsErythromycinRatsDisease Models AnimalTolerance inductionAnesthesiology and Pain MedicineAnesthesiamedicine.symptombusinessAnesthesiology
researchProduct

The antibiotic erythromycin induces tolerance against transient global cerebral ischemia in rats (pharmacologic preconditioning).

2006

Background Cerebral ischemic tolerance can be induced by a variety of noxious stimuli, but no clinically applicable regimen for preconditioning has been described. Therefore, the authors tested the ability of a pharmacologic preconditioning strategy using the well-known macrolide antibiotic erythromycin to induce tolerance against transient global cerebral ischemia in vivo. They also investigated whether tolerance induction by erythromycin involves transcriptional and translational changes of cerebral B-cell leukemia/lymphoma-2 (bcl-2) expression. Methods Male Wistar rats were treated with erythromycin (25 mg/kg intramuscularly) or vehicle and subjected to 15 min of transient global cerebr…

MaleIschemiaHippocampusErythromycinPharmacologyNeuroprotectionHippocampusIn vivomedicineAnimalsRNA MessengerRats WistarIschemic PreconditioningAntibacterial agentNeuronsbusiness.industrymedicine.diseaseAnti-Bacterial AgentsErythromycinRatsTolerance inductionAnesthesiology and Pain MedicineProto-Oncogene Proteins c-bcl-2Ischemic Attack TransientImmunologyReperfusionIschemic preconditioningbusinessmedicine.drugAnesthesiology
researchProduct

Tolerance-Inducing Dose of 3-Nitropropionic Acid Modulates bcl-2 and bax Balance in the Rat Brain: A Potential Mechanism of Chemical Preconditioning

2000

Many studies have reported ischemia protection using various preconditioning techniques, including single dose 3-nitropropionic acid (3-NPA), a mitochondrial toxin. However, the cellular signal transduction cascades resulting in ischemic tolerance and the mechanisms involved in neuronal survival in the tolerant state still remain unclear. The current study investigated the mRNA and protein expression of the antiapoptotic bcl-2 and the proapoptotic bax, two antagonistic members of the bcl-2 gene family, in response to a single dose of 3-NPA, to global cerebral ischemia–reperfusion, and to the combination of both 3-NPA-pretreatment and subsequent global cerebral ischemia–reperfusion. Brain h…

MalePathologymedicine.medical_specialtyIschemiaPharmacologyBiology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBcl-2-associated X proteinDrug toleranceProto-Oncogene ProteinsGene expressionmedicineAnimalsRNA MessengerRats WistarIschemic Preconditioningbcl-2-Associated X ProteinMessenger RNABrainDrug ToleranceNitro Compoundsmedicine.diseasePathophysiologyRatsReal-time polymerase chain reactionProto-Oncogene Proteins c-bcl-2NeurologyIschemic Attack TransientApoptosisbiology.proteinNeurology (clinical)PropionatesCardiology and Cardiovascular Medicine030217 neurology & neurosurgeryJournal of Cerebral Blood Flow & Metabolism
researchProduct

BCL-2 UPREGULATION AFTER 3-NITROPROPIONIC ACID PRECONDITIONING IN WARM RAT LIVER ISCHEMIA

2008

We aimed to determine whether 3-nitropropionic acid (3-NPA) preconditioning protects rat livers against warm ischemia/reperfusion injury. We hypothesized that 3-NPA mediates its protective effects by Bcl-2 upregulation. Brown-Norway rats (200 g) were injected with 3-NPA (10 mg/kg intraperitoneally) 24 h before 90 min of selective warm in situ ischemia. In additional experiments, 30-day survival was studied after 90 min of warm liver ischemia and resection of nonischemic liver tissue. We demonstrate increased mRNA and protein levels of Bcl-2 by real-time polymerase chain reaction, immunohistochemistry, and Western blot analysis in 3-NPA-pretreated rats. All treated animals survived, whereas …

Malemedicine.medical_specialtyBlotting WesternIschemiaCritical Care and Intensive Care MedicineLipid peroxidationchemistry.chemical_compoundstomatognathic systemWestern blotDownregulation and upregulationInternal medicinemedicineAnimalsWarm IschemiaIschemic PreconditioningCaspasechemistry.chemical_classificationReactive oxygen speciesmedicine.diagnostic_testbiologyCaspase 3Reverse Transcriptase Polymerase Chain ReactionNitro Compoundsmedicine.diseaseImmunohistochemistryCaspase 9RatsEndocrinologyLiverProto-Oncogene Proteins c-bcl-2chemistryApoptosisReperfusion InjuryEmergency Medicinebiology.proteinPropionatesReperfusion injuryShock
researchProduct

Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients.

2001

Abstract Objective: To investigate the free radicals (FR) generation after ischaemic preconditioning and cardiopulmonary bypass and during reperfusion in CABG patients, and the role of ischaemic preconditioning. Methods: Forty-three CABG patients were randomised into an ischaemic preconditioning and a control group. The protocol for ischaemic preconditioning was two cycles of 2-min ischaemia followed by 3-min reperfusion. Free radicals were measured using electron spin resonance spectroscopy. Global and right heart functions were collected. Results: The free radicals generation in coronary sinus blood in the ischaemic preconditioning group was 9.7 and 16.6% after the ischaemic preconditioni…

Malemedicine.medical_specialtyFree RadicalsIschemiaCardiac indexMyocardial IschemiaHemodynamicsVentricular Function Leftlaw.inventionRight ventricular ejection fractionPostoperative ComplicationslawInternal medicineCardiopulmonary bypassmedicineHumansRadiology Nuclear Medicine and imagingCardiac OutputCoronary Artery BypassCoronary sinusAgedMyocardial StunningCardiopulmonary Bypassbusiness.industryStunningHemodynamicsStroke VolumeMiddle Agedmedicine.diseaseAnesthesiaIschemic Preconditioning MyocardialCardiologyIschemic preconditioningSurgeryFemaleCardiology and Cardiovascular MedicinebusinessCardiovascular surgery (London, England)
researchProduct

Short-term ischemia usually used for ischemic preconditioning causes loss of dendritic integrity after long-term survival in the gerbil hippocampus

2006

Ischemic preconditioning has been established as a powerful experimental neuroprotective strategy, both after global and focal cerebral ischemia. Little is known, however, about the structural and functional long-term outcome. Therefore, our present study was designed to check for potential subtle alterations in the hippocampus after long-term survival. Gerbils were subjected either to short-term ischemia of 2.5 min duration usually used for ischemic preconditioning (n=8) or to sham operation (n=6) and allowed to survive for 6 weeks. Hippocampi with neuronal densities comparable to those of sham-operated control animals were analyzed for dendritic marker proteins MAP2, MAP1B and synaptopodi…

Malemedicine.medical_specialtyIschemiaCell CountHippocampal formationBiologyGerbilHippocampusNeuroprotectionInternal medicinemedicineAnimalsHippocampus (mythology)Ischemic PreconditioningMolecular BiologyNeurologic ExaminationGeneral NeuroscienceMicrofilament ProteinsLong-term potentiationDendritesmedicine.diseaseImmunohistochemistryEndocrinologynervous systemIschemic Attack TransientIschemic preconditioningSynaptopodinNeurology (clinical)GerbillinaeMicrotubule-Associated ProteinsNeuroscienceDevelopmental BiologyBrain Research
researchProduct

Zweizeitige Ösophagusresektion mit ischämischer Präkonditionierung des Schlauchmagens bei dekompensiertem Dolichomegaösophagus im Endstadium der Acha…

2008

Development of a megaesophagus with a sigmoid-shaped distal part in patients with achalasia--even in the course of successful myotomy with reduction of the resting pressure of the lower esophageal sphincter--is often the expression of an irreversible progression of the disease. Management of patients with end-stage achalasia and aperistaltic, dilated "burned-out" esophagus--with or without peptic stenosis--is a therapeutic challenge for gastroenterologists and surgeons. We report on a 37-year-old female patient with decompensated dolichomegaesophagus following multiple endoscopic and operative interventions at the lower and upper esophageal sphincters presenting with severe dysphagia and we…

Myotomymedicine.medical_specialtybusiness.industryPepticmedicine.medical_treatmentGastroenterologyMegaesophagusAchalasiaAnastomosismedicine.diseaseDysphagiadigestive system diseasesSurgeryEsophagectomyotorhinolaryngologic diseasesmedicineIschemic preconditioningmedicine.symptombusinessZeitschrift für Gastroenterologie
researchProduct

Pharmacology of Ischemia-Reperfusion. Translational Research Considerations.

2016

Ischemia-reperfusion (IRI) is a complex physiopathological mechanism involving a large number of metabolic processes that can eventually lead to cell apoptosis and ultimately tissue necrosis. Treatment approaches intended to reduce or palliate the effects of IRI are varied, and are aimed basically at: inhibiting cell apoptosis and the complement system in the inflammatory process deriving from IRI, modulating calcium levels, maintaining mitochondrial membrane integrity, reducing the oxidative effects of IRI and levels of inflammatory cytokines, or minimizing the action of macrophages, neutrophils, and other cell types. This study involved an extensive, up-to-date review of the bibliography …

NeutrophilsIschemiaApoptosis030204 cardiovascular system & hematologyPharmacologyurologic and male genital diseasesAntioxidantsProinflammatory cytokineTranslational Research Biomedical03 medical and health sciences0302 clinical medicinemedicineHumanscardiovascular diseasesIschemic PreconditioningOpiate alkaloidurogenital systemMechanism (biology)business.industryTumor Necrosis Factor-alphaMacrophagesOpiate AlkaloidsfungiNF-kappa BComplement System Proteinsmedicine.diseaseApoptosis030220 oncology & carcinogenesisReperfusion InjuryAnesthetics InhalationIschemic preconditioningCytokinesSurgeryTumor necrosis factor alphaInflammation MediatorsbusinessReperfusion injuryJournal of investigative surgery : the official journal of the Academy of Surgical Research
researchProduct